<?xml version="1.0" encoding="UTF-8"?>
<bill>
  <bill-type>h</bill-type>
  <blog-article-count type="integer">9</blog-article-count>
  <hot-bill-category-id type="integer" nil="true"></hot-bill-category-id>
  <id type="integer">41861</id>
  <introduced type="integer">1173416400</introduced>
  <is-frontpage-hot type="boolean">false</is-frontpage-hot>
  <last-speech type="integer" nil="true"></last-speech>
  <last-vote-date type="integer" nil="true"></last-vote-date>
  <last-vote-roll type="integer" nil="true"></last-vote-roll>
  <last-vote-where nil="true"></last-vote-where>
  <lastaction type="integer">1173672000</lastaction>
  <news-article-count type="integer">2</news-article-count>
  <number type="integer">1432</number>
  <page-views-count type="integer">715</page-views-count>
  <pl nil="true"></pl>
  <plain-language-summary nil="true"></plain-language-summary>
  <rolls nil="true"></rolls>
  <session type="integer">110</session>
  <sponsor-id type="integer">400425</sponsor-id>
  <summary>	3/9/2007--Introduced.&lt;br/&gt;Preserve Access to Affordable Generics Act - Amends the Clayton Act to make it unlawful for a person, in connection with the sale of a drug product, to be a party to any agreement resolving or settling a patent infringement claim in which: (1) an abbreviated new drug (generic) application filer receives anything of value; and (2) such filer agrees not to research, develop, manufacture, market, or sell the generic product for any period. Excludes a resolution or settlement that includes no more than the right to market the generic product prior to the expiration of the patent. Amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to set forth additional filing requirements related to agreements between a brand name drug company and a generic drug applicant. Requires the Chief Executive Officer or the company official responsible for negotiating any agreement to file a certification that materials filed with respect to such agreements are complete, final, and exclusive. Amends the Federal Food, Drug, and Cosmetic Act to provide that forfeiture of the 180-day exclusivity period for the marketing of a generic drug occurs if there is a final decision of the Federal Trade Commission (FTC) or the court that an agreement has violated this Act.&lt;br/&gt;</summary>
  <topresident-date type="integer">1173672000</topresident-date>
  <topresident-datetime type="date">2007-03-12</topresident-datetime>
  <updated type="timestamp">Thu Nov 06 19:57:30 -0600 2008</updated>
  <bill-titles type="array">
    <bill-title>
      <as>introduced</as>
      <bill-id type="integer">41861</bill-id>
      <fti-titles>'act':6 'access':2 'afford':4 'generic':5 'preserv':1</fti-titles>
      <id type="integer">44770</id>
      <is-default type="boolean" nil="true"></is-default>
      <title>Preserve Access to Affordable Generics Act</title>
      <title-type>short</title-type>
    </bill-title>
    <bill-title>
      <as>introduced</as>
      <bill-id type="integer">41861</bill-id>
      <fti-titles>'drug':5,10,19 'name':4 'brand':3 'delay':13 'entri':15 'market':22 'compani':6,11 'compens':8 'generic':9,18 'prohibit':2</fti-titles>
      <id type="integer">42135</id>
      <is-default type="boolean" nil="true"></is-default>
      <title>To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.</title>
      <title-type>official</title-type>
    </bill-title>
  </bill-titles>
  <last-action>
    <action-type>action</action-type>
    <amendment-id type="integer" nil="true"></amendment-id>
    <bill-id type="integer">41861</bill-id>
    <created-at type="timestamp" nil="true"></created-at>
    <date type="integer">1173672000</date>
    <datetime type="timestamp">Mon Mar 12 00:00:00 -0500 2007</datetime>
    <how nil="true"></how>
    <id type="integer">124704</id>
    <result nil="true"></result>
    <roll-call-id type="integer" nil="true"></roll-call-id>
    <roll-call-number type="integer" nil="true"></roll-call-number>
    <text>Referred to the Subcommittee on Commerce, Trade and Consumer Protection.</text>
    <vote-type nil="true"></vote-type>
    <where nil="true"></where>
  </last-action>
  <sponsor>
    <biography nil="true"></biography>
    <bioguideid>W000215</bioguideid>
    <birthday type="date">1939-09-12</birthday>
    <blog-article-count type="integer">14265</blog-article-count>
    <congress-office>2204 Rayburn House Office Building</congress-office>
    <contact-webform>http://www.house.gov/waxman/contact.htm</contact-webform>
    <district>30</district>
    <email nil="true"></email>
    <fax>202-225-4099</fax>
    <firstname>Henry</firstname>
    <fti-names>'d':4 'ca':5 '-30':6 'rep':1 'henri':2,7,9 'waxman':3,8,10</fti-names>
    <gender>M</gender>
    <id type="integer">400425</id>
    <lastname>Waxman</lastname>
    <metavid-id>Henry_A._Waxman</metavid-id>
    <middlename>A.</middlename>
    <name>Rep. Henry Waxman [D, CA-30]</name>
    <news-article-count type="integer">6541</news-article-count>
    <nickname nil="true"></nickname>
    <osid>N00001861</osid>
    <page-views-count type="integer">13914</page-views-count>
    <party>Democrat</party>
    <phone>202-225-3976</phone>
    <religion>Jewish</religion>
    <state>CA</state>
    <sunlight-nickname nil="true"></sunlight-nickname>
    <title>Rep.</title>
    <unaccented-name>Henry Waxman</unaccented-name>
    <url nil="true"></url>
    <user-approval type="float">1.98823529411765</user-approval>
    <watchdog-id nil="true"></watchdog-id>
    <website>http://www.house.gov/waxman/</website>
    <youtube-id nil="true"></youtube-id>
  </sponsor>
  <co-sponsors type="array">
    <co-sponsor type="Person">
      <biography nil="true"></biography>
      <bioguideid>V000128</bioguideid>
      <birthday type="date">1959-01-10</birthday>
      <blog-article-count type="integer">2070</blog-article-count>
      <congress-office>1707 Longworth House Office Building</congress-office>
      <contact-webform>http://vanhollen.house.gov/HoR/MD08/Contact+Information/Web+Contact/Contact+Form.htm</contact-webform>
      <district>8</district>
      <email nil="true"></email>
      <fax>202-225-0375</fax>
      <firstname>Christopher</firstname>
      <fti-names>'d':5 '-8':7 'md':6 'rep':1 'van':3,9,13 'chris':11 'hollen':4,10,14 'christoph':2,8,12</fti-names>
      <gender>M</gender>
      <id type="integer">400415</id>
      <lastname>Van Hollen</lastname>
      <metavid-id>Chris_Van_Hollen</metavid-id>
      <middlename nil="true"></middlename>
      <name>Rep. Christopher Van Hollen [D, MD-8]</name>
      <news-article-count type="integer">1034</news-article-count>
      <nickname>Chris</nickname>
      <osid>N00013820</osid>
      <page-views-count type="integer">7831</page-views-count>
      <party>Democrat</party>
      <phone>202-225-5341</phone>
      <religion>Episcopalian</religion>
      <state>MD</state>
      <sunlight-nickname>Chris</sunlight-nickname>
      <title>Rep.</title>
      <unaccented-name>Christopher Van Hollen</unaccented-name>
      <url nil="true"></url>
      <user-approval type="float">1.1</user-approval>
      <watchdog-id nil="true"></watchdog-id>
      <website>http://vanhollen.house.gov</website>
      <youtube-id nil="true"></youtube-id>
    </co-sponsor>
  </co-sponsors>
  <actions type="array">
    <action type="BillAction">
      <action-type>action</action-type>
      <amendment-id type="integer" nil="true"></amendment-id>
      <bill-id type="integer">41861</bill-id>
      <created-at type="timestamp" nil="true"></created-at>
      <date type="integer">1173672000</date>
      <datetime type="timestamp">Mon Mar 12 00:00:00 -0500 2007</datetime>
      <how nil="true"></how>
      <id type="integer">124704</id>
      <result nil="true"></result>
      <roll-call-id type="integer" nil="true"></roll-call-id>
      <roll-call-number type="integer" nil="true"></roll-call-number>
      <text>Referred to the Subcommittee on Commerce, Trade and Consumer Protection.</text>
      <vote-type nil="true"></vote-type>
      <where nil="true"></where>
    </action>
    <action type="BillAction">
      <action-type>action</action-type>
      <amendment-id type="integer" nil="true"></amendment-id>
      <bill-id type="integer">41861</bill-id>
      <created-at type="timestamp" nil="true"></created-at>
      <date type="integer">1173416400</date>
      <datetime type="timestamp">Fri Mar 09 00:00:00 -0600 2007</datetime>
      <how nil="true"></how>
      <id type="integer">95829</id>
      <result nil="true"></result>
      <roll-call-id type="integer" nil="true"></roll-call-id>
      <roll-call-number type="integer" nil="true"></roll-call-number>
      <text>Referred to House Judiciary</text>
      <vote-type nil="true"></vote-type>
      <where nil="true"></where>
    </action>
    <action type="BillAction">
      <action-type>action</action-type>
      <amendment-id type="integer" nil="true"></amendment-id>
      <bill-id type="integer">41861</bill-id>
      <created-at type="timestamp" nil="true"></created-at>
      <date type="integer">1173416400</date>
      <datetime type="timestamp">Fri Mar 09 00:00:00 -0600 2007</datetime>
      <how nil="true"></how>
      <id type="integer">106237</id>
      <result nil="true"></result>
      <roll-call-id type="integer" nil="true"></roll-call-id>
      <roll-call-number type="integer" nil="true"></roll-call-number>
      <text>Referred to House Energy and Commerce</text>
      <vote-type nil="true"></vote-type>
      <where nil="true"></where>
    </action>
    <action type="BillAction">
      <action-type>introduced</action-type>
      <amendment-id type="integer" nil="true"></amendment-id>
      <bill-id type="integer">41861</bill-id>
      <created-at type="timestamp" nil="true"></created-at>
      <date type="integer">1173416400</date>
      <datetime type="timestamp">Fri Mar 09 00:00:00 -0600 2007</datetime>
      <how nil="true"></how>
      <id type="integer">95828</id>
      <result nil="true"></result>
      <roll-call-id type="integer" nil="true"></roll-call-id>
      <roll-call-number type="integer" nil="true"></roll-call-number>
      <text nil="true"></text>
      <vote-type nil="true"></vote-type>
      <where nil="true"></where>
    </action>
    <action type="BillAction">
      <action-type>action</action-type>
      <amendment-id type="integer" nil="true"></amendment-id>
      <bill-id type="integer">41861</bill-id>
      <created-at type="timestamp" nil="true"></created-at>
      <date type="integer">1173416400</date>
      <datetime type="timestamp">Fri Mar 09 00:00:00 -0600 2007</datetime>
      <how nil="true"></how>
      <id type="integer">106236</id>
      <result nil="true"></result>
      <roll-call-id type="integer" nil="true"></roll-call-id>
      <roll-call-number type="integer" nil="true"></roll-call-number>
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
      <vote-type nil="true"></vote-type>
      <where nil="true"></where>
    </action>
  </actions>
  <roll-calls type="array"/>
</bill>
